# Assessing Gut Microbiome Changes Before and After an Oral Nutritional Supplement Intake Using the SIMBA Capsule in Diabetic Participants

> **NCT06704022** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Nimble Science Ltd.** · enrollment: 30 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** Oral nutritional supplement

## Key facts

- **NCT ID:** NCT06704022
- **Lead sponsor:** Nimble Science Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06704022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06704022, "Assessing Gut Microbiome Changes Before and After an Oral Nutritional Supplement Intake Using the SIMBA Capsule in Diabetic Participants". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06704022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*